Genpharmasec Ltd logo

Genpharmasec Ltd (GENPHARMA) share fundamentals

IndustrialsCommodities Tradingmicro-capNSE / BSE

Genpharmasec Ltd is a micro-cap company in Industrials (Commodities Trading) with a market capitalisation of ₹60 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Industrials company.

Share price₹1.11
Market cap₹60 crore
PE ratio37.72x
ROCE2.4%
Debt / equity0.53x
1-year return-27%

Financial health score

48.8
Caution

Out of 100, across five pillars of reported fundamentals.

Profitability12
Debt & solvency57
Valuation56
Growth69
Governance67

What stands out

Genpharmasec Ltd vs the Industrials median

MetricGENPHARMASector median
PE ratioprice paid for each rupee of yearly profit37.72x18.82xWeaker
Price to bookprice against the book value of assets0.92x1.96xBetter
EV / EBITDAbusiness value against operating profit19.32x12.75xWeaker
Dividend yieldyearly dividend as a share of price—0.5%
Return on equityprofit on shareholders’ money2.4%10.1%Weaker
ROCEprofit on all capital employed2.4%13.3%Weaker
Net profit marginprofit kept from each rupee of sales1.1%5.8%Weaker
Debt to equityborrowing against shareholders’ money0.53x0.26xWeaker
Interest coveragehow many times profit covers interest1.78x5.1xWeaker
Current ratioshort-term assets against short-term dues1.71x1.92xWeaker
Revenue growth (1Y)change in sales over a year289.1%12.5%Better
EPS growth (1Y)change in earnings per share over a year1.3%7.1%Weaker
Promoter holdingshare owned by the founders or parent32.1%61%Weaker
Promoter pledgepromoter shares pledged as loan security0%0%In line
Betahow much it moves with the market0.851.09
1-year returnshare price change over 52 weeks-27%-14.6%
Want a plan built around your money?

Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.

Decide · where to investOpen on the chart

Other Industrials companies

See all Industrials stocks →

Frequently asked questions

What is the PE ratio of Genpharmasec Ltd?

Genpharmasec Ltd trades at a PE of 37.72x as of 5 November 2026, against a Industrials median of 18.82x. PE is the price paid for each rupee of yearly profit.

Is Genpharmasec Ltd debt free?

No. Genpharmasec Ltd has a debt-to-equity ratio of 0.53x, against a Industrials median of 0.26x.

What is the ROCE and ROE of Genpharmasec Ltd?

Genpharmasec Ltd has a return on capital employed of 2.4% and a return on equity of 2.4%. The Industrials medians are 13.3% and 10.1%.

What is the DecideChart health score of Genpharmasec Ltd?

Genpharmasec Ltd scores 48.8 out of 100, graded Caution. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.

Should I buy Genpharmasec Ltd shares?

DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Genpharmasec Ltd with its Industrials peers, and consult a SEBI-registered adviser before investing.

Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.